CHIRAL PHARMACEUTICALS

Abstract

RETURN TO ISSUEPREVNewsNEXTCHIRAL PHARMACEUTICALSDrug firms continue to develop chiral drugs as single enantiomers, to carry out racemic switches, and to use chirality to manage drug life cyclesSTEPHEN C. STINSONView Author Information C&EN NORTHEAST NEWS BUREAUCite this: Chem. Eng. News 2001, 79, 40, 79–97Publication Date (Print):October 1, 2001Publication History Published online13 November 2010Published inissue 1 October 2001https://pubs.acs.org/doi/10.1021/cen-v079n040.p079https://doi.org/10.1021/cen-v079n040.p079newsACS PublicationsCopyright © 2001 AMERICAN CHEMICAL SOCIETYArticle Views81Altmetric-Citations124LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access options SUBJECTS:Catalysts,Inhibitors,Peptides and proteins,Pharmaceuticals,Serum Get e-Alerts